tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

GLGlobe Life

Financials · Life Insurance · NYSE

Globe Life's website is: www.globelifeinsurance.com. 10-K, Item 1

Headquarters
Mckinney, TX
Next results
around Feb 3, 2027
Compare with peers → Embed

10-K 0000320335-26-000090 (2026-02-25) vs 10-K 0000320335-25-000013 (2025-02-26)

SectionCompared textWords nowChanged
Risk FactorsItem 1A5,307 11.7%
MD&AItem 713,190 17.0%
Legal ProceedingsItem 3, via Note 5 – Commitments and Contingencies2,710 49.3%
Accounting PoliciesItem 8, Note 1 – Significant Accounting Policies8,009 12.4%

The redline: what was cut and what was added

In each section, the paragraph that changed most, marked against last year's 10-K: cut words struck through, new words highlighted and underlined.

Legal Proceedings 244 words changed in this paragraph; it is 60% similar to last year's version.
Also pending in the Eastern District of Texas is a consolidated shareholder derivative suit that is closely related to the putative securities class action disclosed above (the “City of Miami Matter”). On November 7, 2024, Globe Life Inc. shareholder Jui Cheng Hsiao (“Hsiao”) filed a shareholder derivative complaint against Globe Life Inc. as a nominal defendant, as well as certain current and former Globe Life Inc. executives and members of Globe Life Inc.’s its Board of Directors. On November 14, 2024, Globe Life Inc. shareholder Gautam Jadhav (“Jadhav”) filed a shareholder derivative complaint against the same set of defendants. Each shareholder derivative complaint asserts one claim for breach of fiduciary duty against the individual defendants and alleges that the individual defendants breached their fiduciary duties to Globe Life Inc. by causing or permitting Globe Life Inc. to make misleading statements about Globe Life Inc.’s its performance and financial results. The allegations are substantially similar to the allegations made in the City of Miami Matter and derive from the Fuzzy Panda a short seller report. Pursuant to Globe Life Inc.'s Restated Certificate of Incorporation and indemnification agreements with the individual defendants, Globe Life Inc. has agreed to indemnify them for all expenses and losses related to the litigation, subject to the terms of those indemnification agreements. On November 25, 2024, January 3, 2025, the two shareholder plaintiffs moved to consolidate Court consolidated the two actions into one and appointed Hsiao and Jadhav as Lead Plaintiffs and their counsel as Lead Counsel for the consolidated derivative action and the Court granted the motion on January 3, 2025 (In re Globe Life Inc. Stockholder Derivative Litigation, Lead Case No. 4:24-cv-00993-ALM (E.D. Tex.)). The case is before the same Court as the City of Miami Matter. On January 16, 25, 2025, the parties filed a Court granted the parties’ joint motion to stay such proceedings pending the Court’s resolution of the motion to dismiss filed by Globe Life Inc. in the City of Miami Matter. The On October 14, 2025, the parties informed the Court granted such joint that the motion to dismiss in the City of Miami Matter was denied and of their agreement for the terms of the stay to remain in place as they coordinated a schedule. On October 27, 2025 and December 5, 2025, the proceedings on January 25, 2025. parties again notified the Court of their continued agreement for the terms of the stay to remain in place and further notified the Court of two related derivative cases filed in the Eastern District of Texas by Globe Life Inc. shareholders, as referenced below.

Source: Item 3, via Note 5 – Commitments and Contingencies, 10-K 0000320335-26-000090 vs Item 3, via Note 5 – Commitments and Contingencies, 10-K 0000320335-25-000013

Accounting Policies 119 words changed in this paragraph; it is 36% similar to last year's version.
Future Policy Benefits: The liability for future policy benefits for traditional and limited-payment long duration life and health products comprises approximately 93% of the total liability for future policy benefits. The liability is determined each reporting period based on the net level premium method. This method requires the liability for future policy benefits be calculated as the present value of estimated future policyholder benefits and the related termination expenses, less the present value of estimated future net premiums to be collected from policyholders. Net level premiums reflect a recomputed net premium ratio using actual experience since the issue date or January 1, 2021, the Transition Date(1), and expected future experience. The liability is accrued as premium revenue is recognized and adjusted for differences between actual and expected experience. Long-duration insurance contracts issued by the Company are grouped into cohorts based on the contract issue year, distribution channel, legal entity, and product type.

Source: Item 8, Note 1 – Significant Accounting Policies, 10-K 0000320335-26-000090 vs Item 8, Note 1 – Significant Accounting Policies, 10-K 0000320335-25-000013

MD&A 106 words changed in this paragraph; it is 35% similar to last year's version.
Net policy obligations amounted to 53% of Health premium increased 9% in 2024 2025 as compared to 51% in both 2023 and 2022. 2024. This increase was primarily due attributable to significant sales growth in our Medicare supplement plans as a result of what we believe is a consumer shift from Medicare Advantage plans to Medicare supplement plans during the assumptions review current year. Premium growth in 2025 was also the result of lapses Medicare supplement rate increases that went into effect in 2025 in addition to an increase in agent count and morbidity resulting in a remeasurement loss of $10.5 million compared to a remeasurement gain of $5.2 million and $10.7 million in 2023 and 2022, respectively. productivity on other health business. Refer to Note 6—Policy Liabilities for further discussion of the Company's annual assumptions review.

Source: Item 7, 10-K 0000320335-26-000090 vs Item 7, 10-K 0000320335-25-000013

Risk Factors 84 words changed in this paragraph; it is 46% similar to last year's version.
We use institutional funding agreements originating from FHLB, which from time to time serve as a significant source of our liquidity. Additionally, we use agreements with the FHLB to meet near-term liquidity needs. If the FHLB were to change its definition of eligible collateral, we could be required to post additional amounts of collateral in the form of cash or other assets. Additionally, if our creditworthiness falls below the FHLB’s requirements or if legislative or other political actions cause changes to the FHLB’s mandate or to the eligibility of life insurance companies to be members of the FHLB system, we could be required to find other sources to replace this funding, which may prove difficult and increase our liquidity risk.

Source: Item 1A, 10-K 0000320335-26-000090 vs Item 1A, 10-K 0000320335-25-000013

Every change, by type

Sentences and paragraphs of GL's Risk Factors and MD&A, 10-K 2026-02-25 against 10-K 2025-02-26. Each links to the text at sec.gov.

Quiet changes are sentences kept from last year with one to four words changed, at least one of them a hedge, a modal or a qualifier (may, could, will, not, significant, material…). A year or date rolling forward is not counted.

The full word listadverse, adversely, all, although, anticipate, anticipates, any, approximately, believe, believes, can, cannot, certain, could, expect, expects, generally, however, if, intend, intends, largely, likely, many, material, materially, may, might, most, must, never, no, not, possible, primarily, probable, should, significant, significantly, some, substantial, substantially, unlikely, will, would

AddedRisk Factors
Our investment portfolio contains certain alternative investments that may be illiquid and volatile, which could negatively affect our investment income and liquidity.

Read it in 10-K 2026-02-25 at sec.gov ↗

AddedRisk Factors
Over the past several years, we have increased our investment in alternative investments, such as limited partnerships. These and other similar investments may have different, more significant risk characteristics than investments in fixed maturity securities, may be more volatile and may be illiquid due to restrictions on sales, transfers and redemption terms, all of which could negatively affect our investment income and overall portfolio liquidity.

Read it in 10-K 2026-02-25 at sec.gov ↗

AddedRisk Factors
These alternative investments may not meet regulatory admissibility requirements or may result in increased regulatory capital charges to the insurance subsidiaries that hold these investments, which could limit those subsidiaries’ ability to pay dividends and negatively impact our liquidity.

Read it in 10-K 2026-02-25 at sec.gov ↗

AddedRisk Factors
Under an intercompany reinsurance agreement initiated in 2025, we have ceded approximately $1.2 billion of our life statutory reserves from Liberty National Life Insurance Company, Globe Life And Accident Insurance Company, and American Income Life Insurance Company to GL Re, as of December 31, 2025. Future regulatory changes made by the BMA or other events may impact the capital efficiency of the reinsurance structure and could require the holding company to contribute additional capital to GL Re or our U.S. insurance subsidiaries to recapture ceded business.

Read it in 10-K 2026-02-25 at sec.gov ↗

AddedRisk Factors
transmit, store, and retrieve valuable data. In addition, in the event that a significant number of our management were unavailable following a disaster, the achievement of our strategic objectives could be negatively impacted.

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedRisk Factors
Additionally, any violation or alleged violation of law or regulations could result in significant legal costs or in legal proceedings that may result in monetary and legal remedies being imposed against the Company, which could have a material adverse effect on our business, financial condition or results of operations.

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedRisk Factors
As of the date of this Report, one putative securities class action has and five shareholder derivative lawsuits have been filed against Globe Life Inc. and we expect that other putative class action claims may be filed as well. related to this event.

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedRisk Factors
Any incident affecting confidential information systems resulting from the above factors could damage our reputation in the marketplace, deter potential customers from purchasing our products, result in the loss of existing customers, subject us to significant civil and criminal liability, constrain cash flows, or require us to incur significant technical, legal, or other expenses.

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedRisk Factors
The failure to maintain effective and efficient information systems at the Company or manage responsible use of emerging technologies, including artificial intelligence, could adversely affect our financial condition and results of operations. operations at the Company.

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedRisk Factors
Our insurance subsidiaries are subject to various state statutory and regulatory restrictions applicable to insurance companies that limit the amount of cash dividends, loans, and advances that those subsidiaries may pay to us, including laws establishing minimum solvency and liquidity thresholds. in addition, our Bermuda reinsurance subsidiaries are subject to regulation established by the Bermuda Monetary Authority ("BMA").

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedRisk Factors
The reliance on these third-party vendors creates a number of business risks, such as the risk that the Company may not maintain service quality, control or effective management of the outsourced business operations and that the Company cannot control the data, facilities, networks, emerging technology or information systems, facilities or networks of such systems used by third-party vendors.

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedRisk Factors
Press coverage and other public statements that allege wrongdoing, even if untrue, can lead to increased regulatory inquiries or investigations including any that may arise in connection with the subpoenas from U.S. investigations.

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedRisk Factors
We employ controls and procedures designed to facilitate service quality of our third party third-party vendors and mitigate risks resulting from the use of third-party vendors; however, such controls and procedures cannot be 100% effective in all cases.

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedRisk Factors
In addition, these reports resulted in significant negative publicity against us, damaged our reputation, and exposed us to resulted in a putative securities class action litigation and derivative shareholder litigation.

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedRisk Factors
Since April 2024, we We have been and continue to be the target of several short sellers who have published reports making allegations about the Company, which resulted in a significant decline in the price of our common stock.

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedRisk Factors
This modernization includes the responsible innovative, responsible, and secure use of emerging technologies like artificial intelligence. intelligence ("AI").

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedRisk Factors
Other sources of liquidity include a variety of short-term and long-term instruments, including our credit facility, Pre-Capitalized Trust Securities ("P-CAPS") facility, commercial paper, long-term debt, Federal Home Loan Bank (FHLB), ("FHLB"), intercompany financing and reinsurance.

Read it in 10-K 2026-02-25 at sec.gov ↗

Quiet changesRisk Factors
In addition, if If we do not provide an attractive career opportunity with competitive compensation as well as motivation for producing agents to increase sales of our products, our growth could be impeded.

Read it in 10-K 2026-02-25 at sec.gov ↗

Quiet changesRisk Factors
Such determination is not binding but we expect any potential civil action brought by the EEOC would likely include such an allegation.

Read it in 10-K 2026-02-25 at sec.gov ↗

AddedMD&A
Globe Life serves the lower-middle to middle-income market. We believe this market is underserved, has significant growth potential, and provides us with a distinct competitive advantage. This advantage is protected due not only to our ability to efficiently reach this market through both exclusive and direct to consumer distribution channels, but also due to the amount of data and experience we possess, as we have been in this same market for over 60 years with essentially the same products. The basic protection life and health insurance products we offer are specifically designed to help provide financial security to consumers in this market.

Read it in 10-K 2026-02-25 at sec.gov ↗

AddedMD&A
Net remeasurement gains of $134.3 million in 2025, $46.3 million in 2024, and $3.2 million in 2023 were attributable to the Company's annual third-quarter review and unlocking of life and health long-term assumptions, including lapses, mortality and morbidity. See the remeasurement gain/loss table in Note 6—Policy Liabilities for additional information.

Read it in 10-K 2026-02-25 at sec.gov ↗

AddedMD&A
To enhance comparability of underlying operating performance across periods, the Company also evaluates life underwriting margin on a normalized basis that excludes the impacts of annual assumption updates. As discussed above, assumption unlocking results in a cumulative catch-up remeasurement gain or loss recognized in policy obligations. While required under GAAP, these remeasurement effects can introduce volatility unrelated to current-period underwriting performance.

Read it in 10-K 2026-02-25 at sec.gov ↗

AddedMD&A
Normalized life underwriting margin is a non-GAAP financial measure defined as insurance underwriting margin excluding the impacts of assumption unlocking recognized in the period. Management believes this measure provides investors and other users of the financial statements with additional insight into the underlying profitability and trends of the in force life business by removing the effects of assumption changes that vary by period. On a normalized basis, life underwriting margin for 2025 was $1.4 billion or 41% of premium, compared with $1.3 billion or 40% of premium in 2024. In 2023, assumption unlocking had minimal impact with underwriting margin remaining unchanged at 38% of premium. This increase in normalized life underwriting margin in the current year reflects improved underlying mortality and persistency experience and favorable expense efficiency across our Divisions.

Read it in 10-K 2026-02-25 at sec.gov ↗

AddedMD&A
(1) Includes a gain of $14 million related to the recapture of reinsurance for the year ended December 31, 2025 as disclosed in Note 1—Significant Accounting Policies under the caption Reinsurance and Recapture.

Read it in 10-K 2026-02-25 at sec.gov ↗

AddedMD&A
Health premium increased 9% in 2025 as compared to 2024. This increase was attributable to significant sales growth in our Medicare supplement plans as a result of what we believe is a consumer shift from Medicare Advantage plans to Medicare supplement plans during the current year. Premium growth in 2025 was also the result of Medicare supplement rate increases that went into effect in 2025 in addition to an increase in agent count and productivity on other health business. Refer to Note 6—Policy Liabilities for further discussion of the Company's annual assumptions review.

Read it in 10-K 2026-02-25 at sec.gov ↗

AddedMD&A
Consistent with the life segment, the Company also evaluates health underwriting margin on a normalized basis that excludes the impacts of annual assumptions unlocking recognized in policy obligations. Normalized health underwriting margin is a non-GAAP financial measure and should not be considered a substitute for GAAP underwriting margin. Management believes this measure provides useful supplemental information regarding underlying health underwriting performance by removing period specific assumption update effects.

Read it in 10-K 2026-02-25 at sec.gov ↗

AddedMD&A
On a normalized basis, health underwriting margin for 2025 was $387 million or 25% of premium, compared with $383 million or 27% of premium in 2024 and $373 million or 28% of premium in 2023. The percentage of premium decline primarily reflects higher claims experience and an increase in the proportion of overall health premium from United American. As with life, reported GAAP underwriting margin for all periods presented was affected by assumption unlocking as discussed above.

Read it in 10-K 2026-02-25 at sec.gov ↗

AddedMD&A
In 2025, we entered into a 30-year facility agreement (“Facility Agreement”) with a Delaware Trust (the “Trust”) formed by us in connection with the sale by the trust of $500 million pre-capitalized trust securities redeemable May 15, 2055 in a Rule 144A private placement. The Trust invested the proceeds from the sale of its securities in a portfolio of principal and interest strips of U.S. Treasury securities (the “Strips”).

Read it in 10-K 2026-02-25 at sec.gov ↗

RemovedMD&A
As previously noted, a component of insurance underwriting margin is policy obligations, which includes for each reporting period the change in the liability for future policy benefits (LFPB). The LFPB is determined each reporting period based on the net level premium method. Net level premiums reflect a recomputed net premium ratio using actual experience since the issue date, and expected future experience based on future cash-flow assumptions. See Note 6—Policy Liabilities for additional information. The policy liability is accrued as premium revenue is recognized and adjusted for differences between actual and expected experience in the form of remeasurement gains and losses during the period. If actual mortality, morbidity, and lapse experience equals our expected assumptions used in the development of our liability for future policy benefits, there would be no impact to our financial results. Actual experience can have a material impact on financial results to the extent it significantly deviates from the expected assumptions which are used to develop our estimates of the liability for future policy benefits and amortization of the deferred acquisition cost asset (DAC). For example, deviations in actual versus expected lapses in the early policy years tend to have a larger impact on DAC amortization than LFPB change in reserves. Conversely, deviations in actual versus expected lapses in the later policy years typically have a larger impact on LFPB change in reserves than DAC amortization. This is due to the release of DAC and LFPB where DAC capitalization in earlier years is amortizing over time and the LFPB is increasing over time as the policy stays inforce. Disaggregated rollforwards of our present value of expected future net premiums and our expected future policy benefits are presented within Note 6—Policy Liabilities, which include disclosure of remeasurement gain (loss) for the effect of actual variances from expected experience and the changes in assumptions (mortality, morbidity, and lapses) on future cash flows.

Read it in 10-K 2025-02-26 at sec.gov ↗

RemovedMD&A
The Company performed an annual review of its assumptions in the third quarter of 2024 that resulted in favorable changes to its mortality and lapse assumptions on life and unfavorable changes to morbidity assumptions on health. In our life segment mortality assumptions generally decreased across most channels in line with recent experience consistent with decreasing levels of excess deaths. Lapse rate assumptions in the life segment were slightly increased across all channels. For the health segment, morbidity assumptions were increased, causing higher future policy benefit reserves. The assumption review process of the life and health segments resulted in a $46.3 million net remeasurement gain for the period ended December 31, 2024 as compared to a $3.2 million net remeasurement gain for the period ended December 31, 2023 and a $36.5 million net remeasurement loss for the period ended December 31, 2022.

Read it in 10-K 2025-02-26 at sec.gov ↗

RemovedMD&A
Excluding the impact of assumption changes, the Company's results for actual variances from expected experience for both life and health produced a $57.4 million net remeasurement gain for the period ended December 31, 2024, as compared to a $38.0 million net remeasurement gain for the period ended December 31, 2023 and a $4.6 million net remeasurement gain for the period ended December 31, 2022.

Read it in 10-K 2025-02-26 at sec.gov ↗

RemovedMD&A
Approximately 90% of our premiums are collected monthly; however, other premium payment options such as quarterly and annual are offered by the Company and may be elected by the policyholder. The majority of premiums are paid by way of automatic draft or electronic payment from our policyholders and to a lesser extent from other payment methods such as check, credit card, and worksite payroll deduction.

Read it in 10-K 2025-02-26 at sec.gov ↗

RemovedMD&A
Excluding our Direct to Consumer Division, we sell our policies primarily through independently contracted agents (“agents”) who earn commissions in accordance with contracts they have with the respective insurance subsidiary of the Company. These contract arrangements with agents cover commission structures and rates, contract periods, credit terms for settlement of agent advance accounts, vesting rights in future renewal commissions upon termination of contracts and responsibility for certain premium collections. Contract terms with agents vary, but generally commissions are earned over the life of the policy as premiums are paid. Commissions are calculated on a policy-by-policy basis and vary by product type and policy year. Commission rates are higher for the first-year premium when a policy is issued and are generally reduced for policies that remain in effect for renewal periods (e.g., commission rates may reduce in years 2-10 and again in year 11 and after). After a certain period (typically 10 years), commission rates become constant over the remaining life of the policy and are considered level commissions.

Read it in 10-K 2025-02-26 at sec.gov ↗

RewordedMD&A
This improvement was primarily due to improved mortality and the assumptions updated annual assumption changes which were based upon our review of lapses, mortality, and morbidity resulting in a remeasurement gain of $130.9 million in 2025 compared to a remeasurement gain of $56.8 million compared to in 2024 and a remeasurement loss of $2.0 million in 2023 and a remeasurement loss of $47.2 million in 2022. 2023.

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedMD&A
Investment Net investment income grew declined in the current period due to the lower growth in invested assets and the higher lower earned yields on new investments relative short-term investments, commercial mortgage loans, and limited partnerships compared to the yield on dispositions and average portfolio yield. prior year.

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedMD&A
In 2024, 2025, underwriting margin in the health segment decreased increased to $372 $390 million due to higher claim utilization, increased sales and rate increases in our Medicare supplement business, compared with $372 million in 2024 and $378 million in 2023 and $377 million in 2022. 2023.

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedMD&A
The division Division experienced a 10% 14% rise in health net sales in 2024 2025 as compared with 2023, 2024, primarily due to an increase in producing agents increased agent count and improved increased agent productivity and training. productivity.

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedMD&A
Investment-grade corporate securities $ 727,259 $ 1,258,203 $ 967,588 $ 812,697 Investment-grade municipal securities 114,621 94,658 572,654 599,946 Other securities 76,259 29,577 — 7,577 Total fixed maturity acquisitions(1) $ 918,139 $ 1,382,438 $ 1,540,242 $ 1,420,220 Effective annual yield (one year compounded)(2) 6.37 % 5.93 % 6.13 % 5.18 % Average life (in years, to next call) 29.7 29.4 18.0 13.5 Average life (in years, to maturity) 33.9 33.3 24.8 22.8 Average rating A A- A A

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedMD&A
(Dollar amounts in thousands)Year Ended December 31, 2025 2024 2023 Balance at beginning of period $ 529,120 $ 529,511 $ 542,497 Downgrades by rating agencies 130,225 101,018 117,731 Upgrades by rating agencies (30,565) (76,754) (32,540) Dispositions (126,293) (40,907) (95,060) Acquisitions 26,735 20,292 — Provision for credit losses (130) (3,280) (6,811) Amortization and other (7,760) (760) 3,694 Balance at end of period $ 521,332 $ 529,120 $ 529,511

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedMD&A
Underwriting margin as a percent of premium was 54% in 2025, compared with 56% in 2024 and 2023. 2024, primarily due to an increase in policy obligations in the current year.

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedMD&A
Due to the long-term nature of our fixed maturity investments and liabilities and the strong cash flows consistently generated by our insurance subsidiaries, we have the ability to hold our securities to maturity.

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedMD&A
Systems that have been put in place, including the addition of a A CRM platform and enhanced analytical capabilities, capabilities have helped the agents develop additional worksite marketing opportunities as well as and improve the productivity of agents selling in the individual life market.

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedMD&A
The net unrealized loss position in the fixed-maturity portfolio increased decreased from $1.0 billion at December 31, 2023 to $1.7 billion at December 31, 2024 to $1.2 billion at December 31, 2025 due to an increase a change in market rates during the period.

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedMD&A
Cash and short-term investments were $459 million at the end of 2025, compared with $250 million at the end of 2024 compared with $185 million at the end of 2023. 2024.

Read it in 10-K 2026-02-25 at sec.gov ↗

RewordedMD&A
Underwriting margin as a percent of premium for the Division was 6% in 2025 and 8% in 2024, declining due to increased claims utilization, 11% in 2023, and 12% in 2022. 2024.

Read it in 10-K 2026-02-25 at sec.gov ↗

Quiet changesMD&A
The Liberty National Division Division's average producing agent count increased significantly when compared with the prior-year comparable periods.

Read it in 10-K 2026-02-25 at sec.gov ↗

Quiet changesMD&A
While both the American Income Life Division and the Direct to Consumer Division primarily sell life insurance, they also market health products.

Read it in 10-K 2026-02-25 at sec.gov ↗

Work on GL in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/GL/export.csv") into a cell.